Global Cholestatic Pruritus Market Size, Share, and COVID-19 Impact Analysis, By Therapeutic Class (Biologics, Small Molecule Inhibitors, Topical Agents, Systemic Corticosteroids, and Others), By Indication (Chronic Kidney Disease-Associated Pruritus (CKD-aP), Atopic Dermatitis, Psoriasis, Cholestatic Pruritus, and Other Dermatological Conditions), By Route of Administration (Injectable, Oral, Topical, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
$5550
Total
$5550
Need assistance?
Call us or write to us:
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies